Dr. Jacob M Bell, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 530000 Breitenbush Rd, Detroit, OR 97342 Phone: 503-724-8351 |
News Archive
Asthmatic patients may soon have a more effective way to control the condition, thanks to a new pharmacological discovery by researchers from the National University of Singapore.
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, was awarded the Medical Technology Award and its owner and CTO, Phil Isaacson received the Technology Executive of the Year by the Minnesota High Tech Association (MHTA), in partnership with Enterprise Minnesota and LifeScience Alley.
In the first national study of the prevalence of antibiotic-resistant Acinetobacter baumannii infections in children across the US, researchers from Center for Disease Dynamics, Economics, & Policy (CDDEP) in Washington, DC and Rush University in Chicago, IL examined national and regional trends of antibiotic resistance in clinical specimens over a 13-year period.
The longer the period of time a child is bullied, the more severe and lasting the impact on a child's health, according to a new study from Boston Children's Hospital published online Feb. 17 in Pediatrics. The study is the first to examine the compounding effects of bullying from elementary school to high school.
› Verified 3 days ago